...
【24h】

Excitatory Mechanism of Deflationary Slowly Adapting Pulmonary Stretch Receptors in the Rat Lung

机译:收缩缓慢适应大鼠肺收缩的兴奋机制

获取原文
获取原文并翻译 | 示例
           

摘要

The excitatory responses of deflationary slowly adapting pulmonary stretch receptor (SAR) activity to lung deflation ranging from approximately -15 to -25 cm of H_2O for approximately 5 s were examined before and after administration of flecainide, a Na~+ channel blocker, and K~+ channel blockers, such as 4-aminopyridine (4-AP) and tetracethylamonium (TEA). The experiments were performed in anesthetized, artificially ventilated rats after unilateral vagotomy. The deflationary SARs increased their activity during lung deflation and its effect became more pronounced by increasing the degree of negative pressure. During lung deflation the average values for the deflationary SAR adaptation index (Al) were below 40%. Intravenous administration of veratridine (50 #mu#g/kg), an Na~+ channel opener, stimulated deflationary SAR activity: one maintained excitatory activity mainly during deflation and the other receptrors showed a tonic discharge during both deflation and inflation. Despite the difference in deflationary SAR firing patterns after venatridine administration, flecainide treatment (6.0 mg/kg) blocked veratridine-induced deflationary SAR stimulation and also caused strong inhibition of the excitatory responses of deflationary SARs to lung deflation. Under these conditions, the average values for deflation. Under these conditions, the average values for deflationary SAR Al were over 90%. The responses of deflationary SARs deflationary SAR Al to lung deflation were not significantly altered by pretreatment with either 4-AP (0.7 and 2.0 mg/kg) or TEA (2.0 and 6.0 mg/kg). These results suggest that the excitatory effect of lung deflation on deflationary SAR actiivty is mediated by the activation of flecainide-sensitive Na~+ channels on the nerve terminals of deflationary SARs.
机译:在服用氟卡尼,Na〜+通道阻滞剂和K之前和之后,检查了通缩缓慢适应性肺拉伸受体(SAR)活性对H_2O约-15至-25 cm H_2O约5 s的兴奋性反应。 〜+通道阻滞剂,例如4-氨基吡啶(4-AP)和四乙基铵(TEA)。实验是在单侧迷走神经切断术后在麻醉的人工通气大鼠中进行的。通气性SAR在肺通气过程中增加了其活性,其作用通过增加负压程度而变得更加明显。在肺通气期间,通气SAR适应指数(A1)的平均值低于40%。静脉注射维他命(50#mu#g / kg)是一种Na〜+通道开放剂,可刺激通缩性SAR活性:一种主要在通气过程中维持兴奋性,而其他受体在通气和通气过程中均表现为强直性放电。尽管使用韦那啶后通缩性SAR激发方式有所不同,氟卡尼治疗(6.0 mg / kg)阻止了维拉替丁诱导的通缩性SAR刺激,并且还强烈抑制了通缩性SAR对肺通气的兴奋性反应。在这些条件下,放气的平均值。在这些条件下,通缩SAR Al的平均值超过90%。放气性SAR的通气性SAR Al对肺通气的反应,用4-AP(0.7和2.0 mg / kg)或TEA(2.0和6.0 mg / kg)的预处理均无明显改变。这些结果表明,肺通气对通气性SAR活性的兴奋作用是由通气性SAR的神经末梢上对flecainide敏感的Na〜+通道的激活介导的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号